VanEck Associates’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
Other funds holding DOX
BGC
BIP
VanEck Associates's DOX Position: Q2 2026 in Review
VanEck Associates reduced its Amdocs (DOX) stake by 15% in Q2 2026, selling an estimated $322K and leaving 30,496 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1078.
VanEck Associates first reported a position in DOX in Q4 2013 and has held it in 25 quarters since. The position peaked at $3.4M in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- VanEck Associates held 30,496 shares of Amdocs worth $1.54M as of Q2 2026.
- VanEck Associates sold 5,245 Amdocs shares in Q2 2026, an estimated $322K.
- Amdocs made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1078 holding.
- VanEck Associates first reported a position in Amdocs in Q4 2013 and has held it in 25 quarters since.
- VanEck Associates's Amdocs position peaked at $3.4M in Q1 2025.
- 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.